54
Participants
Start Date
June 1, 2021
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Vitamin K Antagonist - Drug
"Only clinical data (number and types of severe bleeding events, HAS-BLED score, CHA2DS2-VASc score) are collected during the follow-up:~* For cases when they received an anticoagulant treatment and during the 12 months preceding this treatment,~* For controls during the same periods of their cross-matched cases when reciving anticoagulant treatment."
Hemophilia treatment center of caen, Caen
Hemophilia treatment center of Brest, Brest
Hemophilia treatment center of Rennes, Rennes
Hemophilia treatment center of Nantes, Nantes
Hemophilia treatment center of Le Mans, Le Mans
Hemophilia treatment center of Rouen, Rouen
Groupe Maladies hémorragiques de Bretagne
OTHER